Catalyst Pharmaceuticals (FRA:CN2) Purchase Of Investment : €0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Catalyst Pharmaceuticals Purchase Of Investment?

Catalyst Pharmaceuticals's purchase of investment for the three months ended in Mar. 2024 was €0.0 Mil. It means Catalyst Pharmaceuticals spent €0.0 Mil on purchasing investments. Catalyst Pharmaceuticals's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Dec. 2023 ), Catalyst Pharmaceuticals spent the same money on purchasing investments in Mar. 2024 (€0.0 Mil).

Catalyst Pharmaceuticals Purchase Of Investment Historical Data

The historical data trend for Catalyst Pharmaceuticals's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catalyst Pharmaceuticals Purchase Of Investment Chart

Catalyst Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Investment

Get a 7-Day Free Trial

-31.25

-8.22

-8.85

-12.35

Catalyst Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Catalyst Pharmaceuticals Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Catalyst Pharmaceuticals Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Catalyst Pharmaceuticals's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Catalyst Pharmaceuticals (FRA:CN2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Catalyst Pharmaceuticals Inc (FRA:CN2) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

CPRX:USA

Address

355 Alhambra Circle, Suite 801, Coral Gables, FL, USA, 33134

Website

https://www.catalystpharma.com

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Catalyst Pharmaceuticals (FRA:CN2) Headlines

No Headlines